The detection of aneugenic chemicals is important due to the implications of aneuploidy for human health. Aneuploidy can result from chromosome loss or nondisjunction due to chromosome mis-segregation at anaphase. Frequently, aneugens are detected using the in vitro micronucleus assay (IVM), with either centromere or kinetochore labeling. However, this method does not consider nondisjunction, the suggested predominant mechanism of spindle poison induced aneugenicity in primary human lymphocytes. Therefore, the IVM may be relatively insensitive in detecting aneuploidy. To investigate whether chromosome distribution analysis, specifically of nondisjunction, using chromosome-specific centromeric probes provides a more sensitive assay for aneugen detection, six reference aneugens with differing modes of action were tested on human lymphoblastoid TK6 cells. The results show that chromosome loss is a substantial part of the process leading to aneuploidy in TK6 cells. This differs from previous studies on human lymphocytes where nondisjunction has been described as the major mechanism of aneugenicity. However, in the current study more cells and types of aneugenic damage were analyzed. Although compound specific effects on nondisjunction were identified, chromosome distribution analysis did not provide increased sensitivity for the detection of aneugens: For the six reference aneugens examined, chromosome loss was shown at the same concentrations or lower than nondisjunction, even when nondisjunction levels were comparatively high. Therefore, in TK6 cells methods that detect chromosome loss, eg, the IVM, provide a more sensitive technique for the detection of aneugens than the measurement of nondisjunction.
Aneuploidy can result from any compound that disrupts the cell division apparatus and manifests via two main processes. The first process is nondisjunction of chromosomes at anaphase, eg, through inappropriate attachment of the mitotic spindle resulting in the production of a 3:1 or 4:0 distribution of the chromosomes between the two daughter nuclei. The second process is chromosome loss, occurring if a chromosome lags at the metaphase plate due to misattachment of the spindle and is not incorporated into either daughter nuclei. The lost chromosome may be retained as a micronucleus, reincorporated into either daughter nuclei or lost from the cell (Parry et al., 2002) .
The most commonly used technique to investigate the aneugenic potential of compounds is the in vitro micronucleus assay (IVM) in combination with either centromere or kinetochore labeling. Micronuclei form in dividing cells from either acentric chromosome fragments (clastogenic events) or from whole chromosomes lost during telophase (aneugenic events), which are then enveloped in a nuclear membrane to give rise to an extranuclear body (Fenech, 2000) . The expression of micronuclei is dependent upon cell division. Therefore, the identification of cells that have divided at least once during or after treatment is important. These can be identified through the use of a modification of the IVM which utilizes cytochalasin-B, an inhibitor of cytokinesis, leading to the formation of binucleated cells post mitosis (Fenech and Morley, 1985) . There are several methods available to discriminate micronuclei induced by clastogenic and aneugenic events. These include the use of autoantibodies against kinetochores from patients with CREST syndrome (Moroi et al., 1980) , antibodies against human centromeric proteins, and fluorescence in situ hybridization (FISH) using an alphoid DNA probe p82H specific to a centromeric sequence found on all human chromosomes (Mitchell et al., 1985) . These methods discriminate clastogens and aneugens based on the proportion of induced micronuclei containing centromeric DNA or kinetochore protein; aneugens produce mainly centromere/ kinetochore-positive micronuclei (Cþ ve MN) and clastogens mainly centromere/kinetochore-negative CÀ ve MN (Becker et al., 1990) . Fluorescence in situ hybridization has been developed extensively over the last 20 years and is currently the most frequently used technique (Cavallo et al., 2007; Melo et al., 2014) . Where commercial pan-centromeric FISH probes are unavailable for the species in question, eg, the rat, kinetochore labeling is required (Doherty, 2012) . Fluorescence in situ hybridization has the advantage that it can be used to examine chromosome segregation in human and mouse cells, specifically nondisjunction events, using chromosome-specific centromeric probes in binucleate cells (Figure 1 ). Alternative approaches to examine micronuclei by flow cytometry also can discriminate between aneugenic and clastogen micronuclei (Bryce et al., 2011; Muehlbauer and Schuler, 2005) .
Studies in binucleated human lymphocytes using chromosome-specific probes to analyze nondisjunction and chromosome loss have suggested that nondisjunction is the predominant type of damage induced by spindle poisons including colchicine, vinblastine, carbendazim, and nocodazole (Bentley et al., 2000; Elhajouji et al., 1997; Marshall et al., 1996; Sgura et al., 1997; Zijno et al., 1994) . If nondisjunction is the driving the mechanism of aneuploidy induction for spindle poisons, the analysis of chromosome segregation may provide a more sensitive assessment of aneugenic risk and the calculation of thresholds based on no observed effect level or lowest observed effect level (Kirsch-Volders et al., 2002) . However, many interstudy differences could affect the interpretation of results from chromosome segregation analysis. These include differences in the chromosomes chosen for analysis, the method used to analyze chromosome loss, whether the analysis was restricted to binucleates with the expected number of hybridization signals and whether the frequency of nondisjunction was extrapolated from the chromosomes analyzed to the whole chromosome set to give "total nondisjunction".
The aim of the present work is to determine if assessment of nondisjunction provides a more sensitive assay for aneugen detection. Due to the limited data available on the effects of spindle poisons on nondisjunction and chromosome loss in different cells types, the transformed human B lymphoblastoid TK6 cell line was selected for use in this investigation based on this cell lines' human origin, the availability of chromosome specific centromeric probes and its routine for genotoxicity studies in this laboratory.
MATERIALS AND METHODS
All chemicals and reagents were purchased from Sigma-Aldrich (UK) unless otherwise stated.
Cell line and cell culture conditions. The transformed human B lymphoblastoid TK6 cell line was purchased from the European Collection of Cell Cultures (ECACC; cell line number 95111735). It has a modal chromosome number of 47 and a composite karyotype of 47 XY, þder13t(13; 22), der14t(14; 20), der21t(21, 3) . The composite karyotype was achieved from 20 metaphases by G banding and confirmed by FISH (Fellows et al., 2014; Molloy et al., 2010) . The average doubling time of the cells was approximately 16-17 h . Cells were confirmed as mycoplasma free and were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated donor horse serum, 2 mmol/l L-glutamine, 2 mmol/l sodium pyruvate, 200 IU/ml penicillin and 200 mg/ml streptomycin, at 37 C in a humidified atmosphere of 5% CO 2 in air.
Reference aneugen selection. The present work considered reference aneugens suitable for method validation. All selected reference aneugens act via differing modes of action (see Table 1 ). Colchicine and vinblastine were selected as they are two of the most potent and extensively studied aneugens for their effects on chromosome loss and nondisjunction (Elhajouji et al., 1997; Marshall et al., 1996; Zijno et al., 1996) . Taxol, chloral hydrate, and diethylstilbestrol were selected based on their inclusion in the European Union Project: The detection and evaluation of aneugenic chemicals (Parry et al., 1996) . Noscapine was included based on its use as a positive control in the FDA drug approval package for crizotinib (FDA, 2011) , in which 98% of micronucleated cells were kinetochore positive. This is an unusually high proportion as potent aneugens typically only produce about 70%-80% kinetochore positive micronuclei (ICH, 2011). A Binds tubulin (Bryan, 1972) : Inhibits microtubule (MT) polymerization. Does not disrupt preformed MTs. Also shown to alter structure of kinetochores and to effect elongation of daughter centrioles (Parry and Sors, 1993) . Vinblastine Plant alkaloid (Vinca alkaloid: Catharanthus roseus)
Chemotherapeutic agent (antimitotic properties).
Binds tubulin, distinct site to colchicine (Bryan, 1972) : Inhibits MT polymerization, causes preformed MTs to disassemble and crystallization of tubulin. Also shown to cause the formation of multipolar spindles, anaphase dislocations and lagging (Parry and Sors, 1993 Tubulin binding has not been shown. May act by inhibiting tubulin or MT-associated proteins. Inhibits elongation of the spindle by affecting pole to pole MT formation (Parry and Sors, 1993) . Action has been suggested to be a result of alterations in the level of cytosolic free Ca 2þ (Lee et al., 1987) .
Diethylstilbestrol
Synthetic estrogen Therapeutic drug for highrisk pregnancies to prevent spontaneous abortions. Growth promoter for cattle.
Binds tubulin (two binding sites, one at or near to that of colchicine): Destabilizes conformation of tubulin and inhibits MT assembly (Metzler and Pfeiffer, 1995) . Induces exposure of hydrophobic areas and sulfhydryl groups and inhibits intrachain cross-linking of tubulin (Prasad et al., 1999) . Mitomycin C (clastogen)
DNA alkylator isolated from bacteria Therapeutic drug used as antitumor agent.
Specifically alkylates and cross-links guanines in CpG sequences, causing covalent links between the complementary strands of DNA, and inhibition of DNA synthesis and replication (Gargiulo et al., 1994) .
clastogen, mitomycin C (MMC), was also included in this investigation as a negative control.
In vitro cytokinesis-block micronucleus (CBMN) assay. The treatment regime was based on the in vitro cytokinesis-block micronucleus assay as described by Doherty (2012) . Replicate flasks of TK6 cells were dosed with compounds for 24 h, after which the cells were centrifuged, washed one time with culture media. One replicate flask was treated with cytochalasin-B (5 mg/ml) to produce binucleates and the other replicate flask was untreated to produce mononucleates for cytotoxicity measurements. All flasks were returned to the incubator to recover for 24 h. This treatment schedule aligns with the OECD test guideline 487 (OECD, 2011), with sampling times of one to two cell cycles from the beginning of test treatment. Slides were prepared using a cytocentrifuge (Shandon Cytospin 3) by addition of 850 ll of cell suspension into a Shandon Megafunnel, followed by centrifugation at 1000 rpm for 8 min for centromeric labeling or 800 rpm for 8 min for chromosome distribution analysis. Slides were fixed in 100% methanol for 10-15 min and then air-dried at room temperature.
Cytotoxicity measure. Cytotoxicity was measured by relative population doubling (RPD), calculated in the mononucleate cultures from the start of the treatment period until slide preparation, 48 h later. Population doubling (PD) was calculated as:
where N 0 is the initial cell number and N 48 is the post-treatment cell number at 48 h. RPD was calculated as:
Fluorescence in situ hybridization. Three or more concentrations were selected for analysis by FISH, based on a combination of the micronucleus and cytotoxicity data. Slides were dehydrated for at least 24 h prior to centromeric labeling. Labeling was carried out using a HYBrite programmable hotplate and following labeling slides were mounted with Vectashield antifading agent containing 4',6-diamidino-2-phenylindole (DAPI). Fluorescence in situ hybridization was performed as previously described (Doherty, 2012) .
Pan-centromeric labeling. For each slide, 1 ml of human chromosome pan-centromeric paint (Cambio, UK) was mixed with 10 ml of hybridization buffer (Cambio, UK) on a 22 Â 22 mm coverslip. Slides were prewarmed to 42 C for 10 min prior to labeling. The following program was utilized for centromeric labeling: Denaturation at 69 C for 5 min and hybridization at 42 C for->16 h. On completion, the coverslip was removed and the slide was washed for 1 min in 0.4 Â saline-sodium citrate (SSC) buffer with 0.06% v/v of Tween 20 at 73.5 C, followed by 2 min in 2Â SSC plus one drop of Tween 20 at room temperature. Slides were scored manually using a fluorescent microscope with a triple band-pass filter. Micronucleus scoring was terminated after 100 micronuclei per slide had been analyzed for the presence of a centromeric signal (Figure 2) or if a total of 5000 binucleates had been examined.
Chromosome-specific centromeric labeling. Chromosomes 7 and 8 were selected for analysis in this investigation because TK6 cells possess two undamaged copies (Fellows et al., 2014; Molloy et al., 2010) . For each slide, 10 ml of premixed centromere-specific probe (Qbiogene) for chromosomes 7 (FITC, green) and 8 (Cy3, red) were placed on a small round coverslip. Chromosomes were labeled using the following program: Denaturation at 76 C for 5 min and hybridization at 37 C for >16 h. On completion, the coverslip was removed and the slide was washed for 10 s in 0.4Â SSC with 0.06% v/v of Tween 20 at 73.5 C, followed by 1.5 min in 2Â SSC at room temperature. Slides were scanned and imaged ( Figure 3 ) using a fluorescent microscope with a triple band-pass filter and the automated image-analysis program Metacyte (MetaSystems GmbH, Germany). Following this, the slides were scored manually and aberrant events for each chromosome were categorized as shown in Table 2 (based on categories defined by Marshall et al., 1996) . The number and distribution of red and green signals were recorded in at least 200 binucleates per slide, unless there were insufficient analyzable cells. Statistical analysis. For the assays, a v 2 test with one-tailed P-values was used to determine the statistical significance of differences between controls and treated samples for each assay individually.
RESULTS
TK6 cells were dosed with the six reference aneugens, colchicine, vinblastine, taxol, diethylstilbestrol, noscapine, and chloral hydrate, and the clastogen mitomycin C. Following treatment binucleated cells were analyzed using two separate assays: The IVM with pan-centromeric labeling and a FISHbased chromosome distribution assay for chromosomes 7 and 8. The ranges and means of aberrant events observed in solvent control containing cultures (DMSO or water) are shown in Table 3 . The results from the centromeric labeling and chromosome distribution analyses for each reference aneugen and mitomycin C are shown in Table 4 . Statistical significance is calculated relative to concurrent solvent controls and results are considered as biologically relevant when they are outside of the solvent control range (Table 3 ). The data presented represent a single assay run for each compound. Multiple experiments were conducted and overall results obtained were the same but it was not possible to combine experiments due to shifts in toxicity between repeat experiments. The results for all the reference aneugens tested show that chromosome loss (as measured by pan-centromeric labeling or with chromosome-specific probes) was detected at the same or lower concentration as any statistically significant aberrant chromosome distribution event, including nondisjunction (Table 4) .
Colchicine was the strongest inducer of nondisjunction with 11% of chromosome sets affected at the highest concentration tested (58% RPD), and the only compound for which the contribution of nondisjunction to the total increase in aberrant chromosome sets appeared to be greater than that of chromosome loss. This effect of colchicine on nondisjunction is in line with results from published investigations, ie, nondisjunction and chromosome loss frequencies were similar (Elhajouji et al., 1997; Marshall et al., 1996; Zijno et al., 1996) . However, in these studies nondisjunction was detected with statistical significance at lower concentrations than chromosome loss. In contrast, in the chromosome distribution analysis in the current study colchicine induced a clear increase (statistically and biologically relevant) in nondisjunction and chromosome loss at the same concentration, and in the IVM significant increase in induced Cþ ve micronuclei was detected at a lower concentration. Therefore, the nondisjunction analysis was no more sensitive than chromosome loss analysis in detecting aneugenicity.
Vinblastine induced a concentration-dependent increase in chromosome loss and induced the highest frequency of chromosome loss of all the reference aneugens tested (29.3% of chromosome sets affected at the highest concentration). However, it should be noted that this concentration was highly cytotoxic (16% RPD) and a statistically significant increase in nondisjunction was only observed at the highest concentration tested. Therefore, chromosome loss was the more sensitive measure of the aneugenicity of vinblastine. This result is in disagreement with data collected in previous studies of human lymphocytes (Marshall et al., 1996; Zijno et al., 1996) . Taxol behaved similarly to vinblastine, inducing higher levels of chromosome loss than nondisjunction. Diethylstilbestrol and noscapine had more subtle effects on chromosome distribution. No significant increases in nondisjunction were seen at any concentrations tested and although the data suggest that chromosome loss is the more important process, this was not as evident as for vinblastine and taxol. Chloral hydrate appeared to be the weakest of the six reference aneugens tested and did not significantly increase either nondisjunction or chromosome loss in the chromosome distribution analysis. However, it did cause a significant increase in centromerepositive micronuclei and in total aberrant chromosome distribution events when all endpoints were analyzed.
In the chromosome specific assay mitomycin C, a reference clastogen, did not have a significant effect on any category of aneugenic event, except for a single dose at high cytotoxicity (32% RPD) which showed a significant increase in chromosome loss (Table 4 ). This result confirms that chromosome distribution analysis using chromosome-specific probes can be used to distinguish clastogens and aneugens.
DISCUSSION
The results obtained with the reference aneugens tested show that chromosome loss, rather than nondisjunction, is a substantial part of the process leading to aneuploidy in TK6 cells. Responses varied between these aneugens, but all induced statistically and biologically relevant increases in the frequency of chromosome loss at a concentration the same as or lower than nondisjunction. Only colchicine showed an increase in nondisjunction that was greater than the increase in chromosome loss at the same concentration in the chromosome distribution assay. Nevertheless, in the IVM colchicine an increase in Cþ ve MNBN was observed at lower concentrations. These investigations demonstrate that chromosome loss in the IVM is at least an equal, if not a more sensitive, end-point for the detection of aneuploidy as compared to nondisjunction measured using a chromosome distribution assay, in the TK6 cell line in this laboratory.
The results of this study show that not all aneugens not all aneugens result or cause NDJ. Therefore, an assay that relies solely on nondisjunction will miss aneugenic compounds. This result is unsurprising because "aneugen" is an umbrella term for the many mechanisms that result in the loss or gain of a chromosome (Aardema et al., 1998) and although the reference aneugens tested were all spindle poisons which bind tubulin, they do so through different modes of action and affinities (see Table 1 ). Consequently, some may affect the spindle apparatus resulting into NDJ and others in chromosome loss.
The results from the current investigation using TK6 cell line differs from the results obtained in previous studies in primary human lymphocytes, in which nondisjunction is reported as the main process that leads to aneuploidy (Bentley et al., 2000; Elhajouji et al., 1997; Marshall et al., 1996; Sgura et al., 1997; Zijno et al., 1996) . Possible reasons for these differences are discussed below.
Firstly, it is difficult to directly compare frequencies of micronuclei with those of aberrant chromosome events because the IVM detects micronucleated cells produced as a consequence of chromosome loss events involving all chromosomes, while the chromosome distribution assay involves the analysis of only two chromosomes. Therefore, the latter one can only provide an estimate of the percentage of cells affected by aberrant events involving all chromosomes. Elhajouji et al. (1997) and Sgura et al. (1997) extrapolated data from two chromosomespecific probes to estimate total nondisjunction for all chromosomes-they multiplied the frequency of cells with nondisjunction for the two chromosomes analyzed by 23/2. This type of analysis relies on the assumption that nondisjunction occurs randomly and independently for all chromosomes. This contrasts previous reports which have shown that different chromosomes occur at different frequencies in micronuclei following treatment due to differences in spindle alignment sequence or the relative number of microtubules attached to the kinetochore (Caria et al., 1996; Fauth et al., 2000; Norppa and Falck, 2003; Wuttke et al., 1997) . This calculation will also overestimate total nondisjunction as it does not take into account the probability of multiple events occurring to different chromosomes within the same cell. The in vitro micronucleus showing chromosome loss is powered differently to the nondisjunction assay looking at segregation of chromosomes, which may contribute to the relative sensitivities of these assays when directly compared. The utilization of a different cell type, ie, in this investigation the TK6 cell line, may affect comparative analysis between studies. TK6 cells have been shown to produce good concordance with results produced in human lymphocytes for chromosome aberration and micronucleus assays (Pfuhler et al., 2011) and they have been shown to have a relatively stable karyotype with few changes observed for up to 4 weeks of continuous culture (Molloy et al., 2010) . However, TK6 cells do differ karyotypically from normal human cells. They have a modal chromosome number of 47 and 3 characteristic abnormalities: 47, XY þ 13, 14qþ, 21pþ (Grosovsky et al., 1996) . Therefore, in this study chromosomes 7 and 8 were analyzed due to an unaltered chromosome number and no visible chromosomal abnormalities.
When comparing the relative sensitivity of the IVM centromeric labeling and chromosome distribution analyses it is important to consider the differences in sample sizes between the two methods. For centromeric labeling up to 5000 cells were analyzed per concentration for the presence of a centromerepositive micronucleus. As the analysis of chromosome distribution is more time consuming than micronuclei scoring, only 200 cells (400 chromosome sets) were analyzed per concentration. This difference in statistical power could explain why the detection of aneugenic events via chromosome distribution analysis did not offer greater sensitivity than the IVM, even though more aberrant events were detected by this method.
When comparing the results of the present investigation with those of earlier investigations, differences in study design that may affect the analysis and interpretation of results should be considered. For example, Zijno et al. (1996) and Sgura et al. (1997) analyzed nondisjunction and chromosome loss using pairs of chromosome-specific probes and restricted their analysis to only cells containing the expected number of hybridization signals (ie, four signals for each chromosome per binucleate cell), so as to exclude technical artefacts caused by signal overlap, poor probe penetration or nonspecific binding. Using this analysis, cells displaying chromosome loss (eg, 2:1, 2:0, and 1:0 distributions) were disregarded and only chromosome loss where the missing probe was retained in the cell in a micronucleus were recorded. Therefore, the frequency of chromosome loss may be underestimated and that of nondisjunction artificially elevated. In fact, our results using chromosomespecific FISH probes suggest that chromosome loss in a micronucleus is a rare event compared to the complete loss of a chromosome.
The use of chromosome-specific probes in binucleates allows tracking and analysis of chromosomes through mitosis into the daughter cells to be analyzed. From this, a prediction of what aneugenic events may have occurred can be made. Both chromosome loss and nondisjunction have the potential to generate a large variety of aberrant chromosome distributions ( Figure 4 ). As the spindle microtubules are attached to the chromosomes in a nondisjunction event, the assumption is that the most likely outcome will be a 3:1 or 4:0 distribution and that it is unlikely that a chromosome would then be lost to give 2:1 or 3:0. However, when a chromosome lags at the metaphase plate it may be lost, perhaps forming a micronucleus, or it may be reincorporated into either daughter nuclei resulting in a 3:1 distribution, so appearing as nondisjunction, or a 2:2 distribution, so appearing normal (Parry et al., 2002) .
In summary, the results from this investigation show that IVM and thus, chromosome loss, was a more sensitive assay for aneugenicity than NDJ in this laboratory in the TK6 human lymphoblastoid cell line. For all six reference aneugens examined, chromosome loss was shown at the same or lower concentrations than nondisjunction, even when nondisjunction levels were comparatively high (eg, colchicine).
